equipment included in 
 accounts payable and 
 accrued liabilities                      6,928                     2,595 
 
 
                         MONTAUK RENEWABLES, INC. 
                       NON-GAAP FINANCIAL MEASURES 
                               (Unaudited) 
 
(in thousands): 
 
The following table provides our EBITDA and Adjusted 
 EBITDA, as well as a reconciliation to net income 
 which is the most directly comparable GAAP measure 
 for the three and nine months ended September 30, 
 2024 and 2023, respectively: 
 
 
 
                             For the three months ended September 30, 
                                   2024                    2023 
                          -----------------------  --------------------- 
Net income                  $              17,048   $             12,934 
Depreciation, depletion 
 and amortization                           6,048                  5,346 
Interest expense                            1,835                  1,295 
Income tax expense                          3,965                  2,808 
                          ---  ------------------      ----------------- 
   Consolidated EBITDA                     28,896                 22,383 
 
Impairment loss                               533                     51 
Net loss on sale of 
assets                                          1                     -- 
                          ---  ------------------      ----------------- 
   Adjusted EBITDA          $              29,430   $             22,434 
                          ===  ==================      ================= 
 
 
 
                             For the nine months ended September 30, 
                                   2024                    2023 
                          -----------------------  --------------------- 
Net income                  $              18,186   $             10,149 
Depreciation, depletion 
 and amortization                          17,305                 15,792 
Interest expense                            4,285                  3,681 
Income tax expense                          4,722                  2,681 
                          ---  ------------------      ----------------- 
   Consolidated EBITDA                     44,498                 32,303 
 
Impairment loss                             1,232                    777 
Net loss on sale of 
 assets                                        72                     37 
Transaction Costs                              61                     86 
                          ---  ------------------      ----------------- 
   Adjusted EBITDA          $              45,863   $             33,203 
                          ===  ==================      ================= 
 

(END) Dow Jones Newswires

November 12, 2024 16:30 ET (21:30 GMT)